GeneDx Holdings Corp. (WGS), Monday announced preliminary financial results, reporting revenues of approximately $427 million and $121 million for full year 2025 and fourth quarter, respectively.
The company noted that revenues increased by 41 percent and 27 percent year-over-year in full year 2025 and fourth quarter, respectively.
On average, analysts estimate revenues of $427.04 million and $120.49 million for full year 2025 and fourth quarter, respectively.
Looking ahead, the company expects revenue of $540 to $555 million for full year 2026.
Analysts, on average, anticipate revenue of $531.02 million for full year 2026.
In the pre-market hours, WGS is trading at $124.01, down 8.40 percent on the Nasdaq.
For comments and feedback contact: editorial@rttnews.com
Business News
June 19, 2026 16:46 ET Major central banks continued to dominate the economic news flow this week too, led by the Federal Reserve, as they announced their latest policy decisions. The Federal Reserve policy session was in focus as it was the first to be led by the new chief Kevin Warsh. In Europe, central banks of the U.K. and Switzerland announced their rate decisions. In Asia, the Bank of Japan drew attention for its policy moves, while data out of China threw some light on the state of the economy.